|
|
 |
|
| | |
| | | | | |
gene
|
|
PR:000004530 |
zinc-alpha-2-glycoprotein
|
AZGP1
|
"A protein that is a translation product of the human AZGP1 gene or a 1:1 ortholog thereof." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-gene
|
|
PR:P25311 |
zinc-alpha-2-glycoprotein (human)
|
hAZGP1
|
"A zinc-alpha-2-glycoprotein that is encoded in the genome of human." [PRO:DNx, UniProtKB:P25311]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000046451 |
zinc-alpha-2-glycoprotein, signal peptide removed form (human)
|
hAZGP1/SigPep-
|
"A zinc-alpha-2-glycoprotein (human) that has had the signal peptide removed. UniProtKB:P25311, 21-298." [PRO:DNx, Reactome:R-HSA-5215961]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056239 |
zinc-alpha-2-glycoprotein N-glycosylated 1 (human)
|
hAZGP1/NGlyco:1
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-109 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P25311-1, Asn-109, MOD:00160~GNO:G00912UN." [GlyGen:P25311-1, PMID:26791533, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056240 |
zinc-alpha-2-glycoprotein N-glycosylated 2 (human)
|
hAZGP1/NGlyco:2
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-109 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G02815KT. Example: UniProtKB:P25311-1, Asn-109, MOD:00160~GNO:G02815KT." [GlyGen:P25311-1, PMID:26791533, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056241 |
zinc-alpha-2-glycoprotein N-glycosylated 3 (human)
|
hAZGP1/NGlyco:3
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-109 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G06247RL. Example: UniProtKB:P25311-1, Asn-109, MOD:00160~GNO:G06247RL." [GlyGen:P25311-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056242 |
zinc-alpha-2-glycoprotein N-glycosylated 4 (human)
|
hAZGP1/NGlyco:4
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-109 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G07799LX. Example: UniProtKB:P25311-1, Asn-109, MOD:00160~GNO:G07799LX." [GlyGen:P25311-1, PMID:26791533, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056243 |
zinc-alpha-2-glycoprotein N-glycosylated 5 (human)
|
hAZGP1/NGlyco:5
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-109 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G08293MJ. Example: UniProtKB:P25311-1, Asn-109, MOD:00160~GNO:G08293MJ." [GlyGen:P25311-1, PMID:26791533, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056244 |
zinc-alpha-2-glycoprotein N-glycosylated 6 (human)
|
hAZGP1/NGlyco:6
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-109 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G10486CT. Example: UniProtKB:P25311-1, Asn-109, MOD:00160~GNO:G10486CT." [GlyGen:P25311-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056245 |
zinc-alpha-2-glycoprotein N-glycosylated 7 (human)
|
hAZGP1/NGlyco:7
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-109 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G27947YN. Example: UniProtKB:P25311-1, Asn-109, MOD:00160~GNO:G27947YN." [GlyGen:P25311-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056246 |
zinc-alpha-2-glycoprotein N-glycosylated 8 (human)
|
hAZGP1/NGlyco:8
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-109 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G40926MX. Example: UniProtKB:P25311-1, Asn-109, MOD:00160~GNO:G40926MX." [GlyGen:P25311-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056247 |
zinc-alpha-2-glycoprotein N-glycosylated 9 (human)
|
hAZGP1/NGlyco:9
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-109 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G43734MM. Example: UniProtKB:P25311-1, Asn-109, MOD:00160~GNO:G43734MM." [GlyGen:P25311-1, PMID:26791533, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056248 |
zinc-alpha-2-glycoprotein N-glycosylated 10 (human)
|
hAZGP1/NGlyco:10
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-109 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G59626AS. Example: UniProtKB:P25311-1, Asn-109, MOD:00160~GNO:G59626AS." [GlyGen:P25311-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056249 |
zinc-alpha-2-glycoprotein N-glycosylated 11 (human)
|
hAZGP1/NGlyco:11
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-109 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G72791KH. Example: UniProtKB:P25311-1, Asn-109, MOD:00160~GNO:G72791KH." [GlyGen:P25311-1, PMID:26791533, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056250 |
zinc-alpha-2-glycoprotein N-glycosylated 12 (human)
|
hAZGP1/NGlyco:12
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-109 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G85144OK. Example: UniProtKB:P25311-1, Asn-109, MOD:00160~GNO:G85144OK." [GlyGen:P25311-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056251 |
zinc-alpha-2-glycoprotein N-glycosylated 13 (human)
|
hAZGP1/NGlyco:13
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-109 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G88374WZ. Example: UniProtKB:P25311-1, Asn-109, MOD:00160~GNO:G88374WZ." [GlyGen:P25311-1, PMID:26791533, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056252 |
zinc-alpha-2-glycoprotein N-glycosylated 14 (human)
|
hAZGP1/NGlyco:14
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-109 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G94917XT. Example: UniProtKB:P25311-1, Asn-109, MOD:00160~GNO:G94917XT." [GlyGen:P25311-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056253 |
zinc-alpha-2-glycoprotein N-glycosylated 15 (human)
|
hAZGP1/NGlyco:15
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-112 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G02815KT. Example: UniProtKB:P25311-1, Asn-112, MOD:00160~GNO:G02815KT." [GlyGen:P25311-1, PMID:26791533, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056254 |
zinc-alpha-2-glycoprotein N-glycosylated 16 (human)
|
hAZGP1/NGlyco:16
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-112 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G07799LX. Example: UniProtKB:P25311-1, Asn-112, MOD:00160~GNO:G07799LX." [GlyGen:P25311-1, PMID:26791533, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056255 |
zinc-alpha-2-glycoprotein N-glycosylated 17 (human)
|
hAZGP1/NGlyco:17
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-112 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G08293MJ. Example: UniProtKB:P25311-1, Asn-112, MOD:00160~GNO:G08293MJ." [GlyGen:P25311-1, PMID:26791533, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056256 |
zinc-alpha-2-glycoprotein N-glycosylated 18 (human)
|
hAZGP1/NGlyco:18
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-112 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G43734MM. Example: UniProtKB:P25311-1, Asn-112, MOD:00160~GNO:G43734MM." [GlyGen:P25311-1, PMID:26791533, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056257 |
zinc-alpha-2-glycoprotein N-glycosylated 19 (human)
|
hAZGP1/NGlyco:19
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-112 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G72791KH. Example: UniProtKB:P25311-1, Asn-112, MOD:00160~GNO:G72791KH." [GlyGen:P25311-1, PMID:26791533, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056258 |
zinc-alpha-2-glycoprotein N-glycosylated 20 (human)
|
hAZGP1/NGlyco:20
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-112 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G88374WZ. Example: UniProtKB:P25311-1, Asn-112, MOD:00160~GNO:G88374WZ." [GlyGen:P25311-1, PMID:26791533, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056259 |
zinc-alpha-2-glycoprotein N-glycosylated 21 (human)
|
hAZGP1/NGlyco:21
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-128 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P25311-1, Asn-128, MOD:00160~GNO:G00912UN." [GlyGen:P25311-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056260 |
zinc-alpha-2-glycoprotein N-glycosylated 22 (human)
|
hAZGP1/NGlyco:22
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-128 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G03930BU. Example: UniProtKB:P25311-1, Asn-128, MOD:00160~GNO:G03930BU." [GlyGen:P25311-1, PMID:29741879, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056261 |
zinc-alpha-2-glycoprotein N-glycosylated 23 (human)
|
hAZGP1/NGlyco:23
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-128 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G05933EN. Example: UniProtKB:P25311-1, Asn-128, MOD:00160~GNO:G05933EN." [GlyGen:P25311-1, PMID:29741879, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056262 |
zinc-alpha-2-glycoprotein N-glycosylated 24 (human)
|
hAZGP1/NGlyco:24
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-128 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G08293MJ. Example: UniProtKB:P25311-1, Asn-128, MOD:00160~GNO:G08293MJ." [GlyGen:P25311-1, PMID:26791533, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056263 |
zinc-alpha-2-glycoprotein N-glycosylated 25 (human)
|
hAZGP1/NGlyco:25
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-128 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G10486CT. Example: UniProtKB:P25311-1, Asn-128, MOD:00160~GNO:G10486CT." [GlyGen:P25311-1, PMID:22171320, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056264 |
zinc-alpha-2-glycoprotein N-glycosylated 26 (human)
|
hAZGP1/NGlyco:26
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-128 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G16175ZV. Example: UniProtKB:P25311-1, Asn-128, MOD:00160~GNO:G16175ZV." [GlyGen:P25311-1, PMID:29741879, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056265 |
zinc-alpha-2-glycoprotein N-glycosylated 27 (human)
|
hAZGP1/NGlyco:27
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-128 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G27126ED. Example: UniProtKB:P25311-1, Asn-128, MOD:00160~GNO:G27126ED." [GlyGen:P25311-1, PMID:29741879, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056267 |
zinc-alpha-2-glycoprotein N-glycosylated 29 (human)
|
hAZGP1/NGlyco:29
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-128 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G40664HB. Example: UniProtKB:P25311-1, Asn-128, MOD:00160~GNO:G40664HB." [GlyGen:P25311-1, PMID:29741879, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056268 |
zinc-alpha-2-glycoprotein N-glycosylated 30 (human)
|
hAZGP1/NGlyco:30
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-128 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G47737VJ. Example: UniProtKB:P25311-1, Asn-128, MOD:00160~GNO:G47737VJ." [GlyGen:P25311-1, PMID:29741879, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056269 |
zinc-alpha-2-glycoprotein N-glycosylated 31 (human)
|
hAZGP1/NGlyco:31
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-128 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G58001LT. Example: UniProtKB:P25311-1, Asn-128, MOD:00160~GNO:G58001LT." [GlyGen:P25311-1, PMID:29741879, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056270 |
zinc-alpha-2-glycoprotein N-glycosylated 32 (human)
|
hAZGP1/NGlyco:32
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-128 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G59626AS. Example: UniProtKB:P25311-1, Asn-128, MOD:00160~GNO:G59626AS." [GlyGen:P25311-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056271 |
zinc-alpha-2-glycoprotein N-glycosylated 33 (human)
|
hAZGP1/NGlyco:33
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-128 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G60923RB. Example: UniProtKB:P25311-1, Asn-128, MOD:00160~GNO:G60923RB." [GlyGen:P25311-1, PMID:29741879, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056272 |
zinc-alpha-2-glycoprotein N-glycosylated 34 (human)
|
hAZGP1/NGlyco:34
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-128 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G87051GH. Example: UniProtKB:P25311-1, Asn-128, MOD:00160~GNO:G87051GH." [GlyGen:P25311-1, PMID:29741879, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000056273 |
zinc-alpha-2-glycoprotein N-glycosylated 35 (human)
|
hAZGP1/NGlyco:35
|
"A zinc-alpha-2-glycoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-128 of the amino acid sequence represented by UniProtKB:P25311-1, in which the glycan composition is represented by GlyTouCan:G94917XT. Example: UniProtKB:P25311-1, Asn-128, MOD:00160~GNO:G94917XT." [GlyGen:P25311-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-gene
|
|
PR:Q63678 |
zinc-alpha-2-glycoprotein (rat)
|
rAZGP1
|
"A zinc-alpha-2-glycoprotein that is encoded in the genome of rat." [OMA:Q63678, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-gene
|
|
PR:Q64726 |
zinc-alpha-2-glycoprotein (mouse)
|
mAZGP1
|
"A zinc-alpha-2-glycoprotein that is encoded in the genome of mouse." [OMA:Q64726, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
modification
|
|
PR:000019095 |
zinc-alpha-2-glycoprotein, signal peptide removed form
|
AZGP1/SigPep-
|
"A zinc-alpha-2-glycoprotein that has had the signal peptide removed." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000046451 |
zinc-alpha-2-glycoprotein, signal peptide removed form (human)
|
hAZGP1/SigPep-
|
"A zinc-alpha-2-glycoprotein (human) that has had the signal peptide removed. UniProtKB:P25311, 21-298." [PRO:DNx, Reactome:R-HSA-5215961]
|
|
|
|
|
